Ranbaxy Pharmaceuticals, the largest maker of a generic version of Lipitor, has halted production of the drug until it can figure out why glass particles may have ended up in pills.
Maker of generic Lipitor halts production
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You